Related Experiment Videos
[The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer]
J Morote Robles1, J A Lorente, C Reig
1Servicio de Urología, Hospital General Universitario Vall d'Hebrón, Barcelona.
Actas Urologicas Espanolas
|May 1, 1994
Abstract:
The inversion of PSA/PAP ratio is not common in patients with prostate cancer. Of 215 patients, 7 showed PSA levels below those of PAP (3.2%). All patients had metastatic disease at the time of diagnosis, 57% in multiple organs and tissues, with a Gleason value in all cases 4. Forty-three percent showed no early response to hormone therapy; mean survival interval recorded in these 7 patients was 21 months. Such a situation may suggest a poor prognosis for this neoplasia.